![Daniel Rankin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Rankin
Corporate Officer/Principal at
SWEDISH ORPHAN BIOVITRUM AB
Net worth: 684 445 $ as of 30/06/2026
Profile
Daniel Rankin currently works at Swedish Orphan Biovitrum AB, as Head-Strategy & Corporate Development.
Dr. Rankin received his graduate degree from the University of Leiden, doctorate degree from the University of Helsinki, and undergraduate degree from the University of York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/06/2026 | 14,338 ( 0% ) | 684 445 $ | 30/06/2026 |
Daniel Rankin active positions
| Companies | Position | Start |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01/01/2017 |
Training of Daniel Rankin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Helsinki
 University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
University of York
 University of York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Daniel Rankin
